Seres therapeutics to host virtual investor event highlighting opportunities for microbiome therapeutics in infection protection on january 31, 2022

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that it will host a webcast investor event on monday, january 31, 2022, from 8:30 a.m. to 10:00 a.m. et. the event will focus on the development of microbiome therapeutics as a novel approach for infection protection in medically compromised individuals. clinical data from the company's phase 3 ecospor iii trial found ser-109, an investigational oral microbiome
MCRB Ratings Summary
MCRB Quant Ranking